Ultra-Processed Foods Linked to Early Signs of Parkinson's Disease
Yet despite experts' warnings, ultra-processed foods are satisfying, cheap, and easy, making them popular across much of the world. In the US, more than half of all calories adults consume at home now come from ultra-processed foods.
As researchers race to keep up, the list of suspected risks continues to grow.
According to an international team of researchers who analyzed decades of records from tens of thousands of health workers, people who eat a lot of ultra-processed foods are more likely to have early signs of Parkinson's disease than those who don't.
This does not prove causation, but it does reveal a noteworthy association, especially in the broader context of health concerns related to ultra-processed foods. It also adds to mounting evidence that diet is key to brain health.
"Eating a healthy diet is crucial as it has been associated with a lower risk of neurodegenerative diseases, and the dietary choices we make today can significantly influence our brain health in the future," says co-author Xiang Gao, a nutritional epidemiologist with the Institute of Nutrition at Fudan University in Shanghai.
In the new study, researchers focused on signs of Parkinson's disease that appear before more specific symptoms develop, which can include body pain, constipation, depressive symptoms, excessive daytime sleepiness, and an impaired sense of smell. At this stage, while patients may not have characteristic features of the disease, neurodegeneration may have already begun.
"There's growing evidence that diet might influence the development of Parkinson's disease. Our research shows that eating too much processed food, like sugary sodas and packaged snacks, might be speeding up early signs of Parkinson's disease," Gao says.
The researchers conducted a longitudinal analysis using data from the Nurses' Health Study and the Health Professionals Follow-Up Study, letting them track details about the diet and health of nearly 43,000 people for up to 26 years.
This sample included men and women with an average age of 48 years, who had no history of Parkinson's disease. The subjects had received regular medical exams and completed biennial health questionnaires, which Gao and his colleagues reviewed for early signs of Parkinson's disease.
Subjects also submitted responses to surveys at two- to four-year intervals, offering insight into their dietary habits. Researchers used this to estimate each subject's average daily ingestion of ultra-processed foods, as defined by the Nova classification system for food processing.
The study covered several types of ultra-processed foods, including sauces, spreads, or condiments; artificially or sugar-sweetened beverages; packaged savory snacks; packaged sweets; snacks or desserts; yogurt or dairy-based desserts; and animal-based products.
Subjects were split into five groups based on their consumption of ultra-processed foods. Those in the highest group ate 11 or more servings per day on average, while the lowest group averaged fewer than three daily servings.
The researchers adjusted for factors such as age, alcohol intake, body mass index, caffeine intake, physical activity, and tobacco smoking, among others.
Subjects who ate 11 or more daily servings of ultra-processed foods were 2.5 times likelier to have at least three early signs of Parkinson's disease compared with subjects who ate fewer than three servings per day, the authors report.
Higher consumption of ultra-processed foods was linked with increased risk of almost all early signs of Parkinson's disease used in this study, they found, with the exception of constipation.
There are some important caveats to these findings. They show an association between ultra-processed foods and increased risk for early signs of Parkinson's disease, but more research is needed to clarify the nature of the relationship.
The focus on early signs of Parkinson's disease also involves some ambiguity, as the authors acknowledge, since these are potential hints of the condition rather than definitive indicators.
Many of the early signs – body pain, for example, or daytime sleepiness – are common as people age and don't necessarily herald Parkinson's disease.
All of these features considered in composite, however, are "strongly predictive" of subsequent Parkinson's disease diagnoses, the researchers write.
"Choosing to eat fewer processed foods and more whole, nutritious foods could be a good strategy for maintaining brain health," Gao says.
"More studies are needed to confirm our finding that eating less processed food may slow down the earliest signs of Parkinson's disease."
The study was published in Neurology.
AI Discovers Suspected Trigger of Alzheimer's, And Maybe a Treatment
One Stage of Sleep Seems Critical For Reducing Risk of Dementia
World First: US Baby Treated With Personalized CRISPR Gene-Editing
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
16 hours ago
- Business Insider
Gain Therapeutics price target lowered to $6 from $7 at Roth Capital
Roth Capital lowered the firm's price target on Gain Therapeutics (GANX) to $6 from $7 and keeps a Buy rating on the shares after meeting with its CEO to discuss the company's Phase 1b study evaluating lead candidate GT-02287 in Parkinson's disease. The CSF biomarker data expected in Q4 makes most sense 'to gain preliminary conviction' as it better capitulates pathological changes associated with iPD and GBA1-PD vs. serum biomarker analysis, the analyst tells investors in a research note. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
CBS News
a day ago
- CBS News
Trusty K-9 companion suiting up to keep University of Minnesota medical student safe
A dog named Nova is suiting up for a very special purpose: keeping a close eye on her human, University of Minnesota medical student Wesley Flint. "Everyday we come in and I put on her boots and her lab coat and her goggles," Flint said. It's all part of Nova's personal protection equipment (PPE) routine as Flint's trusted assistant. Nova is led to her work space, a plush mat under a nearby table, and patiently waits until she's needed. "She's my medical alert dog. I'm a Type-1 diabetic," Flint said. "Diabetic alert dogs can actually smell the change in your blood sugar before any glucose sensor can pick it up a lot of the time." Sometimes, Nova can sense a blood-sugar drop up to a half hour before Flint's arm sensor does. "When my blood sugar is low, she'll get off the mat and come over to me and head butt me against the thigh," Flint said. "If she gives me an alert, I can check my sensor to see which way I'm trending. She's pretty accurate. Pretty rare for her to be wrong." Is Flint worried about technology or AI replacing Nova some day? "I don't think AI has a nose yet, and I'm not sure we can manufacture a robotic nose sensitive enough," Flint said.
Tom's Guide
2 days ago
- Tom's Guide
What is central sleep apnea and how can you tell if you have it?
Central sleep apnea (CSA) is a sleep disorder that is less common than obstructive sleep apnea, but it does have some similarities. In the US, CSA is estimated to affect less than 1% of adults over 40. It's a sleep disorder that is caused by a brief lack of communication between your brain and the muscles that control your breathing. CSA is also associated with underlying health conditions such as cardiovascular disease, stroke and primary brain disorders. As with obstructive sleep apnea, it's important to get a diagnosis if you suspect you might have the condition. Undiagnosed CSA can lead to impaired quality of life, and it can also affect your cardiovascular health. We've spoken with a sleep scientist and a sleep medicine and pulmonary medicine specialist to find out more about this less common form of sleep apnea. 'CSA is a sleep disorder in which the brain fails to signal the muscles of respiration, primarily the diaphragm, to make an effort to take a breath,' explains Dr Peter G Polos, a sleep medicine and pulmonary medicine specialist at JFK University Medical Center in New Jersey. 'This can stop breathing for a period during the night, and it then spontaneously resumes normal breathing until the next cycle," he adds. Get instant access to breaking news, the hottest reviews, great deals and helpful tips. "This can occur many times an hour during sleep.' Central sleep apnea can affect people of all ages, but it's more common in older adults, and those with certain health conditions. Some lifestyle factors can also increase your risk of developing CSA. The most common risk factors include: Dr Carleara Weiss, a sleep scientist and sleep science advisor at Aeroflow Sleep, explains that the main risk factor involves having an underlying medical condition, as this can impact the brain's ability to regulate breathing signals to the respiratory muscles. 'These conditions include cardiovascular diseases," she explains. This can include "stroke and congestive heart failure, chronic use of narcotic medication or substance abuse that suppresses the central nervous system, and neuromuscular diseases such as Parkinson's disease, myasthenia gravis (a chronic autoimmune condition), and amyotrophic lateral sclerosis (ALS).' But that's not an exhaustive list. Other conditions, like hypothyroidism and kidney failure can also increase the risk of developing central sleep apnea. 'The most common symptom is pauses of breathing during sleep that are most commonly noted by a bed partner,' says Dr Polos. 'Others include spontaneous awakenings due to shortness of breath, excessive daytime sleepiness, morning headaches and concentration difficulties.' The most common symptom is pauses of breathing during sleep Dr Weiss adds that people may also wake during the night gasping for air. 'Other symptoms include mood swings, anxiety, depression, sexual dysfunction, and frequent nighttime awakenings,' she says. Cheynes-Stokes breathing can be another symptom of central sleep apnea. It's a cyclical breathing pattern that is characterised by periods of increase and decrease in breathing depth and periods of apnea (where there is a momentary pause in breathing). 'This pattern of breathing is often seen in people who have heart failure and other conditions that can affect the brain's ability to regulate breathing,' Dr Weiss adds. If you have any concerns that you may have signs of this sleep disorder, seeking a diagnosis is a priority. 'The first step is to see a sleep physician who will take a detailed history, review medication and carry out a physical examination,' explains Dr Polos. 'In the end, an overnight sleep study is often the next step to secure the diagnosis.' 'It is important to make this diagnosis because the consequences such as lower oxygen during sleep, can produce strain on the heart and lead to cardiac complications,' he adds. 'Untreated CSA is associated with fatigue and driving risk, concentration decline, and poor quality of life.' Additionally, others could notice changes in your sleep and your health before you realise you have any symptoms. 'If you or your partner have any questions or concerns about the quality or quantity of your sleep, and if those around you observe changes in your mood, energy, performance or concentration, seek advice from your primary care physician or a sleep specialist,' Dr Polos advises. Central sleep apnea treatments can help to improve the quality and quantity of your sleep and improve daytime symptoms. Here are some of the ways CSA can be treated. If you have mild symptoms of CSA, lifestyle changes might be all you need to do in terms of treatment. These include trying to lose weight if you are overweight, keeping active and exercising regularly, and practising good sleep hygiene. For example, making sure your bedroom is dark and quiet and going to bed and waking up at the same time each day. You may find sleeping on your side is helpful too. Making lifestyle changes along with taking prescribed medication may be enough to treat mild to moderate central sleep apnea. 'The first step should be to address any underlying medical conditions,' explains Dr Polos. 'For example, if the patient has heart failure, this needs to be medically managed, which by itself may correct the CSA. 'In addition, reducing or discontinuing any drug that may contribute to CSA must also be considered,' he adds. Treatments that can help to regulate abnormal breathing patterns such as PAP therapy are usually considered after lifestyle changes and medication have been tried, but symptoms of CSA continue. 'The primary mode of treatment is positive airway pressure,' says Dr Polos. 'The modalities can include bilevel positive airway pressure (BiPAP) or adaptive servo-ventilation (AS)." "These are specialised methods of delivering positive pressure to the airways in CSA.' To treat CSA, traditional continuous positive airway pressure (CPAP) is often used, Dr Weiss explains. 'This provides the same pressure during breathing or a BiPAP can provide different pressure levels during inhalation and exhalation. 'Some patients may also qualify for surgery or phrenic nerve stimulation,' she adds, 'and in other cases, a combined therapy of PAP therapy plus medication may be recommended.'
